Vivos (RDGL) Gains from Investment Securities (2017)
Vivos recorded quarterly Gains from Investment Securities of $2800.0 in Q2 2017.
Vivos' Gains from Investment Securities history runs 1 years deep, the most recent figure standing at $2800.0 for Q2 2017.
- In Q2 2017, Gains from Investment Securities changed N/A year-over-year to $2800.0; the TTM figure through Mar 2018 stood at $2800.0 (changed N/A YoY), while the FY2017 annual figure was $2800.0, changed N/A from the prior year.
- Gains from Investment Securities came in at $2800.0 for Q2 2017 at Vivos.
- In the past five years, Gains from Investment Securities ranged from a high of $2800.0 in Q2 2017 to a low of $2800.0 in Q2 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 2,800.00 |
| Jun 30, 2017 | 2,800.00 |